By focusing on community and treatment options that effectively address chronic pain, provide nutritional supplements, and help with mood stabilization, SorsaMED is developing products that will elevate the standard of care for sickle cell patients.  

 

SorsaMED products will derive from our recombinants that fuse nutrient-enriched microalgae with non-psychotropic cannabinoids to produce therapeutic pain management solutions through innovative delivery mechanisms.